Related Experiment Video

Updated: May 31, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

HLA-DRB1 gene polymorphism is associated with idiopathic dilated cardiomyopathy: a meta-analysis

Jinlong Deng1, Rong Luo, Xiaoping Li

  • 1Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, PR China.

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|June 29, 2011
PubMed

Insights

The HLA-DRB1*1401 allele may increase the risk of idiopathic dilated cardiomyopathy, while HLA-DRB1*0901 and HLA-DRB1*0301 alleles may offer protection against this condition.

Area of Science:

  • Immunogenetics
  • Cardiology
  • Human Genetics

Background:

  • The human leukocyte antigen (HLA) system plays a crucial role in immune response.
  • Idiopathic dilated cardiomyopathy (IDCM) is a complex heart condition with potential genetic underpinnings.
  • Previous studies suggest a link between specific HLA-DRB1 alleles and IDCM, but findings are inconsistent.

Purpose of the Study:

  • To conduct a meta-analysis of case-control studies.
  • To clarify the association between HLA-DRB1 alleles and idiopathic dilated cardiomyopathy.
  • To investigate specific alleles: HLA-DRB1*1401, HLA-DRB1*0901, and HLA-DRB1*0301.

Main Methods:

  • Comprehensive literature search across multiple databases (PubMed, SCI, Cochrane, CNKI, CBM, Wanfang, VIP).
  • Inclusion of five case-control studies.
  • Meta-analysis to pool odds ratios (OR) and confidence intervals (CI) for specific HLA-DRB1 alleles.

Main Results:

  • Four studies analyzed for HLA-DRB1*1401 and HLA-DRB1*0901.
  • HLA-DRB1*1401 showed a significantly higher frequency in IDCM patients (OR=2.6, P<0.05).
  • HLA-DRB1*0901 (OR=0.70, P=0.05) and HLA-DRB1*0301 (OR=0.49, P<0.05) were more frequent in healthy individuals, suggesting a protective effect.

Conclusions:

  • The HLA-DRB1*1401 allele may serve as a risk factor for developing idiopathic dilated cardiomyopathy.
  • Conversely, HLA-DRB1*0901 and HLA-DRB1*0301 alleles appear to have a protective effect against IDCM.
  • These findings contribute to understanding the immunogenetic basis of IDCM.
Abstract

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...